IN2014DN08526A - - Google Patents

Info

Publication number
IN2014DN08526A
IN2014DN08526A IN8526DEN2014A IN2014DN08526A IN 2014DN08526 A IN2014DN08526 A IN 2014DN08526A IN 8526DEN2014 A IN8526DEN2014 A IN 8526DEN2014A IN 2014DN08526 A IN2014DN08526 A IN 2014DN08526A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Alex Xenopoulos
Original Assignee
Emd Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49783749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN08526(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emd Millipore Corp filed Critical Emd Millipore Corp
Publication of IN2014DN08526A publication Critical patent/IN2014DN08526A/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/49—Mixing systems, i.e. flow charts or diagrams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/20—Measuring; Control or regulation
    • B01F35/21—Measuring
    • B01F35/2132—Concentration, pH, pOH, p(ION) or oxygen-demand
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/71—Feed mechanisms
    • B01F35/715—Feeding the components in several steps, e.g. successive steps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10061—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN8526DEN2014 2012-06-29 2014-10-13 IN2014DN08526A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261666145P 2012-06-29 2012-06-29
PCT/US2013/045677 WO2014004103A1 (en) 2012-06-29 2013-06-13 Methods for inactivating viruses during a protein purification process

Publications (1)

Publication Number Publication Date
IN2014DN08526A true IN2014DN08526A (de) 2015-05-15

Family

ID=49783749

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8526DEN2014 IN2014DN08526A (de) 2012-06-29 2014-10-13

Country Status (8)

Country Link
US (1) US9809799B2 (de)
EP (2) EP2867359B2 (de)
JP (2) JP6182210B2 (de)
CN (2) CN104411820B (de)
ES (1) ES2895173T3 (de)
IN (1) IN2014DN08526A (de)
SG (1) SG11201406407TA (de)
WO (1) WO2014004103A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2682168A1 (de) 2012-07-02 2014-01-08 Millipore Corporation Reinigung biologischer Moleküle
CN118388581A (zh) * 2013-03-08 2024-07-26 建新公司 治疗性蛋白药物物质的整合连续制造
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
EP4234569A3 (de) 2014-04-15 2023-10-18 Boehringer Ingelheim International GmbH Verfahren und gebrauch zur kontinuierlichen inaktivierung eines virus bei der herstellung eines biologischen produktes
JP6521351B2 (ja) * 2014-10-14 2019-05-29 テックプロジェクトサービス株式会社 ウィルス不活化およびサンプリング装置
US11571635B2 (en) * 2015-03-31 2023-02-07 Cytiva Sweden Ab Liquid chromatography system, a device, and a method
WO2016207328A1 (en) * 2015-06-24 2016-12-29 Glycotope Gmbh PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES
JP7032046B2 (ja) * 2016-01-22 2022-03-08 旭化成メディカル株式会社 生理活性物質の連続的な定流速精製方法
SG11201807824UA (en) * 2016-03-11 2018-10-30 Boehringer Ingelheim Int Methods for continuously inactivating a virus during manufacture of a protein
CN105841984A (zh) * 2016-03-18 2016-08-10 中国石油天然气股份有限公司 聚合物配注工艺设备检测评价装置
US11155794B2 (en) * 2016-08-23 2021-10-26 Alexion Pharmaceuticals, Inc. Method of purifying a heterologous protein from an egg white
CN110891665B (zh) * 2017-05-11 2022-01-14 Emd密理博公司 在连续流动体系中保持窄停留时间分布的机械方法
US11547957B2 (en) * 2017-05-11 2023-01-10 Emd Millipore Corporation Method of maintaining narrow residence time distributions in continuous flow systems
JP6596043B2 (ja) 2017-07-31 2019-10-23 株式会社Ｓｕｂａｒｕ 車両の走行制御システム
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
GB201802593D0 (en) * 2018-02-16 2018-04-04 Fujifilm Diosynth Biotechnologies Uk Ltd Rig
BR112021003420A2 (pt) 2018-08-31 2021-05-18 Genzyme Corporation resina cromatográfica estéril e uso da mesma em processos de manufatura
EP3880806A1 (de) * 2018-11-15 2021-09-22 Bayer HealthCare, LLC Verfahren zur virusinaktivierung zur kontinuierlichen herstellung von antikörpern
US20220041650A1 (en) * 2018-12-03 2022-02-10 Duke University Purification method for recombinant proteins and nanoparticles
CN111269316B (zh) * 2018-12-04 2024-06-28 正大天晴药业集团南京顺欣制药有限公司 抗her2单克隆抗体的纯化方法
SG11202107192VA (en) * 2019-01-23 2021-07-29 Daiichi Sankyo Co Ltd Methods for purifying antibodies comprising of a process by using activated carbon materials
SG11202109015TA (en) * 2019-04-01 2021-09-29 Boehringer Ingelheim Int Integrated and continuous recombinant protein manufacturing
KR102731889B1 (ko) * 2019-07-18 2024-11-19 에이비온 주식회사 2당화된 인터페론-베타 단백질의 정제 방법
FR3099066B1 (fr) 2019-07-26 2021-08-13 Novasep Process Procédé de purification d’une substance cible avec inactivation virale
GB201911686D0 (en) * 2019-08-15 2019-10-02 Fujifilm Diosynth Biotechnologies Uk Ltd Process for purifying target substances
EP4028511A1 (de) * 2019-09-09 2022-07-20 Valneva Austria GmbH Inaktivierungsverfahren für viren
AU2020401034B2 (en) * 2019-12-12 2024-08-29 Eli Lilly And Company Methods for viral inactivation by environmentally compatible detergents
WO2021197249A1 (zh) * 2020-03-30 2021-10-07 上海复宏汉霖生物技术股份有限公司 一种用于靶分子连续纯化的系统和方法
AU2021293805A1 (en) 2020-06-16 2022-12-22 Boehringer Ingelheim International Gmbh A method of providing a homogeneous feed stream within a plug flow reactor
JP2024538673A (ja) * 2021-10-07 2024-10-23 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ｐＨモデリング及び制御のシステム及び方法
EP4357009A1 (de) 2022-10-17 2024-04-24 Sartorius Stedim Biotech GmbH Verfahren und anordnung zum betrieb eines kontinuierlichen downstream-prozesses

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
WO1993017724A1 (en) 1992-03-02 1993-09-16 Bioeng, Inc. Viral inactivation method
JPH09500015A (ja) 1993-06-23 1997-01-07 ニューヨーク ブラッド センター，インコーポレイティド 血液のウィルス不活性化のためのシステム
ATE542891T1 (de) 1994-11-10 2012-02-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freier kultur
US6686191B1 (en) 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin
GB9611698D0 (en) 1996-06-05 1996-08-07 Iatros Ltd Fluid processing
PT973544E (pt) 1997-04-08 2001-12-28 Baxter Ag Preparacao de complexo de protrombina imunotolerante
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
DE19923027C2 (de) 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US20030127603A1 (en) 2001-05-15 2003-07-10 Bernard Horowitz Apparatus for the inactivation of pathogens in protein-containing fluids and uses thereof
EP1415669A1 (de) 2002-09-19 2004-05-06 Aventis Behring GmbH Sterilisationsverfahren für Protein enthaltende biologische Zusammensetzungen
AU2003300951A1 (en) * 2002-12-20 2004-07-22 Baxter International Inc. Fluid treatment method, apparatus and system
US20040256329A1 (en) 2003-06-13 2004-12-23 Peter Meserol Photodynamic biological fluid pathogen inactivation/filtering apparatus and method
US8271139B2 (en) 2003-10-17 2012-09-18 Asahi Kasei Bioprocess, Inc. Multi-stage accurate blending system and method
WO2005090403A2 (en) 2004-03-12 2005-09-29 Biovest International, Inc. Method and apparatus for antibody purification
US8129508B2 (en) 2005-04-11 2012-03-06 Medarex, Inc. Protein purification using HCIC and ion exchange chromatography
WO2009045897A1 (en) 2007-10-03 2009-04-09 Dyax Corp. Systems and methods for purifying proteins
EP2281000A2 (de) 2008-05-15 2011-02-09 Novo Nordisk A/S Antikörperreinigungsverfahren
SG195577A1 (en) * 2008-10-20 2013-12-30 Abbott Lab Viral inactivation during purification of antibodies
TW201024318A (en) 2008-10-20 2010-07-01 Abbott Lab Isolation and purification of antibodies using protein A affinity chromatography
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
KR101580451B1 (ko) * 2009-04-23 2015-12-28 주식회사 동진쎄미켐 연속식 혼합 장치를 이용한 화학 조성물 제조 장치
EP3736338A1 (de) 2009-09-01 2020-11-11 F. Hoffmann-La Roche AG Verbesserte proteinreinigung durch eine modifizierte protein-a-elution
US9527010B2 (en) 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
US9441196B2 (en) † 2010-06-07 2016-09-13 Genzyme Corporation Device for viral inactivation of liquid media
ES2603396T3 (es) * 2010-07-30 2017-02-27 Pfizer Inc Purificación en tándem de proteínas
SG10201508401TA (en) * 2010-10-11 2015-11-27 Abbvie Bahamas Ltd Processes for purification of proteins
JP2013544524A (ja) * 2010-12-06 2013-12-19 ターポン バイオシステムズ，インコーポレイテッド 生物学的生成物の連続プロセス法
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
ES2809211T3 (es) * 2011-07-08 2021-03-03 Emd Millipore Corp Filtros de profundidad mejorados para procesos biotecnológicos desechables
US9096648B2 (en) * 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
CN102492040B (zh) * 2011-12-29 2014-06-25 嘉和生物药业有限公司 一种抗her2或/和抗her3抗体蛋白的纯化方法
EP2682168A1 (de) 2012-07-02 2014-01-08 Millipore Corporation Reinigung biologischer Moleküle
CN118388581A (zh) * 2013-03-08 2024-07-26 建新公司 治疗性蛋白药物物质的整合连续制造
WO2016116947A1 (en) * 2015-01-21 2016-07-28 Indian Institute Of Technology A coiled flow inverter reactor for continuous refolding of denatured recombinant proteins and other mixing operations

Also Published As

Publication number Publication date
JP2017148051A (ja) 2017-08-31
JP2015522017A (ja) 2015-08-03
US20150064769A1 (en) 2015-03-05
EP2867359A4 (de) 2015-11-11
CN104411820B (zh) 2017-05-03
JP6182210B2 (ja) 2017-08-16
EP2867359B1 (de) 2021-09-15
CN107188926B (zh) 2021-02-09
CN104411820A (zh) 2015-03-11
CN107188926A (zh) 2017-09-22
SG11201406407TA (en) 2014-11-27
EP2867359B2 (de) 2024-10-23
EP2867359A1 (de) 2015-05-06
ES2895173T3 (es) 2022-02-17
EP3981873A1 (de) 2022-04-13
JP6457575B2 (ja) 2019-01-23
WO2014004103A1 (en) 2014-01-03
US9809799B2 (en) 2017-11-07

Similar Documents

Publication Publication Date Title
BR112014025798A2 (de)
BR112014017635A2 (de)
BR112014017614A2 (de)
BR112014017690A2 (de)
BR112014017625A2 (de)
BR112014017659A2 (de)
BR112014017592A2 (de)
BR112014017607A2 (de)
BR112014017646A2 (de)
BR112014019577A2 (de)
BR112014017638A2 (de)
AR092201A1 (de)
BR112013027865A2 (de)
BR112014017644A2 (de)
BR112014013184A8 (de)
BR112014017618A2 (de)
BR112014020176A2 (de)
BR112014018782A2 (de)
BR112014017623A2 (de)
BR112014017652A2 (de)
BR112014019005A2 (de)
BR112014017630A2 (de)
BR112014017621A2 (de)
BR112014017631A2 (de)
BR112014017641A2 (de)